Spevigo

Active Ingredient(s): Spesolimab-sbzo
FDA Approved: * September 1, 2022
Pharm Company: * BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Spevigo 60 mg/ml Intravenous Injection
NDC: 0597-0035
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Spevigo 150 mg/ml Intravenous Injection
NDC: 0597-0620
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Spevigo 300 mg/2ml Intravenous Injection
NDC: 0597-7705
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Spevigo 60 mg/ml Subcutaneous Injection
NDC: 50222-360
Labeler:
Leo Pharma Inc.
Spevigo 150 mg/ml Subcutaneous Injection
NDC: 50222-361
Labeler:
Leo Pharma Inc.
Spevigo 300 mg/2ml Subcutaneous Injection
NDC: 50222-362
Labeler:
Leo Pharma Inc.